OBJECTIVES: To determine whether the dose of vitamin A currently recommended by the World Health Organization or half this dose gives better protection against childhood morbidity and mortality. DESIGN: Randomised study. SETTING: A combined oral polio vaccine and vitamin A supplementation campaign in Guinea-Bissau, Africa. PARTICIPANTS: 4983 children aged 6 months to 5 years. INTERVENTIONS: One of two doses of vitamin A (recommended and half); oral polio vaccine. MAIN OUTCOME MEASURES: Mortality and morbidity at six and nine months. RESULTS:Mortality was lower in the children who took half the recommended dose of vitamin A compared with the full dose at both six months (mortality rate ratio 0.69, 95% confidence interval 0.36 to 1.35) and nine months (0.62, 0.36 to 1.06) of follow-up. There was a significant interaction between sex and dose, the lower dose being associated with significantly reduced mortality in girls (0.19, 0.06 to 0.66) but not in boys (1.98, 0.74 to 5.29). The lower dose of vitamin A was consistently associated with lower hospital case fatality in girls (0.19, 0.02 to 1.45). Paradoxically, in children aged 6-18 months, the low dose was associated with slightly higher morbidity. CONCLUSIONS: Half the dose of vitamin A currently recommended by WHO may provide equally good or better protection against mortality but not against morbidity.
RCT Entities:
OBJECTIVES: To determine whether the dose of vitamin A currently recommended by the World Health Organization or half this dose gives better protection against childhood morbidity and mortality. DESIGN: Randomised study. SETTING: A combined oral polio vaccine and vitamin A supplementation campaign in Guinea-Bissau, Africa. PARTICIPANTS: 4983 children aged 6 months to 5 years. INTERVENTIONS: One of two doses of vitamin A (recommended and half); oral polio vaccine. MAIN OUTCOME MEASURES: Mortality and morbidity at six and nine months. RESULTS: Mortality was lower in the children who took half the recommended dose of vitamin A compared with the full dose at both six months (mortality rate ratio 0.69, 95% confidence interval 0.36 to 1.35) and nine months (0.62, 0.36 to 1.06) of follow-up. There was a significant interaction between sex and dose, the lower dose being associated with significantly reduced mortality in girls (0.19, 0.06 to 0.66) but not in boys (1.98, 0.74 to 5.29). The lower dose of vitamin A was consistently associated with lower hospital case fatality in girls (0.19, 0.02 to 1.45). Paradoxically, in children aged 6-18 months, the low dose was associated with slightly higher morbidity. CONCLUSIONS: Half the dose of vitamin A currently recommended by WHO may provide equally good or better protection against mortality but not against morbidity.
Authors: L Rahmathullah; B A Underwood; R D Thulasiraj; R C Milton; K Ramaswamy; R Rahmathullah; G Babu Journal: N Engl J Med Date: 1990-10-04 Impact factor: 91.245
Authors: Lakshmi Rahmathullah; James M Tielsch; R D Thulasiraj; Joanne Katz; Christian Coles; Sheela Devi; Rajeesh John; Karthik Prakash; A V Sadanand; N Edwin; C Kamaraj Journal: BMJ Date: 2003-08-02
Authors: Andrew M Prentice; M Eric Gershwin; Ulrich E Schaible; Gerald T Keusch; Cesar G Victora; Jeffrey I Gordon Journal: J Clin Invest Date: 2008-04 Impact factor: 14.808
Authors: Adam Edvin Roth; Christine Stabell Benn; Henrik Ravn; Amabelia Rodrigues; Ida Maria Lisse; Maria Yazdanbakhsh; Hilton Whittle; Peter Aaby Journal: BMJ Date: 2010-03-15